SCHEMBL6266525

SCHEMBL6266525

CS(=O)(=O)C1=C(C(N)=O)C(c2ccc(C#N)cc2)NC(=O)N1c1cccc(C(F)(F)F)c1

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 20/20 0.67
▸ CYP2C9 P11712 4/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1245247 0.87 ELANE (0.84) ELANECYP2C9
SCHEMBL14819126 0.84 ELANE (0.67) ELANECYP2C9
SCHEMBL6025100 0.81 ELANE (0.76) ELANECYP2C9
SCHEMBL394677 0.81 ELANE (0.85) ELANECYP2C9
SCHEMBL395186 0.81 ELANE (1.00) ELANECYP2C9
SCHEMBL391816 0.81 ELANE (1.00) ELANECYP2C9
SCHEMBL394085 0.81 ELANE (0.85) ELANECYP2C9
SCHEMBL4449580 0.81 ELANE (0.85) ELANECYP2C9
SCHEMBL3719477 0.80 ELANE (0.86) ELANECYP2C9
SCHEMBL122597 0.80 ELANE (0.86) ELANECYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546113-A1 PYRIMIDINONE DERIVATIVES AS THERAPEUTIC AGENTS AGAINST ACUTE AND CHRONIC INFLAMMATORY, ISCHAEMIC AND REMODELLING PROCESSES Bayer HealthCare AG (DE) 2005-06-29 — — EP disclosed
WO-2004024700-A1 PYRIMIDINONE DERIVATIVES AS THERAPEUTIC AGENTS AGAINST ACUTE AND CHRONIC INFLAMMATORY, ISCHAEMIC AND REMODELLING PROCESSES BAYER HEALTHCARE AG (DE) 2004-03-25 — — WO disclosed
Send feedback